COMPANY NEWS


loading
Sun Pharmaceutical Industries Ltd
BSE Code 524715 ISIN Demat INE044A01036 Book Value (₹) 99.25 Div & Yield % 0.96 Market Cap ( Cr.) 400,496.99 P/E * 91.76 EPS * 18.19 Face Value (₹) 1
* Profit to Earning Ratio
* Earning Per Share
Sun Pharma launches Tedizolid Phosphate tablets 200 mg in India Back
(23 Aug 2024)

Sun Pharmaceutical Industries has launched Tedizolid Phosphate tablets 200 mg in India under the brand name “STARIZO”. STARIZO (Tedizolid Phosphate) is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI).

Sun Pharma has obtained rights from Merck Sharp & Dohme Singapore Trading to develop, manufacture and commercialise Tedizolid Phosphate in India.